PMC:6562565 / 43171-43513 JSONTXT

Annnotations TAB JSON ListView MergeView

    MyTest

    {"project":"MyTest","denotations":[{"id":"31244820-25739764-35366140","span":{"begin":94,"end":97},"obj":"25739764"},{"id":"31244820-25739764-35366141","span":{"begin":121,"end":124},"obj":"25739764"},{"id":"31244820-25739764-35366142","span":{"begin":150,"end":153},"obj":"25739764"},{"id":"31244820-25739764-35366143","span":{"begin":190,"end":193},"obj":"25739764"},{"id":"31244820-25739764-35366144","span":{"begin":277,"end":280},"obj":"25739764"},{"id":"31244820-25739764-35366145","span":{"begin":338,"end":341},"obj":"25739764"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"ACT \u0026 intratumoral hypoxia aversion ➣ Respiratory hyperoxia (60%O2)\n➣ T cells:\nTDLN-derived (293) ➣ Melanoma: B16-F10 (293)\n➣ Fibrosarcoma: MCA205 (293) ➣ Primary tumor expansion rate ↓ (293)\nHost A2AR (293)\n➣ Metastasis formation ↓ (293) ↑ Adoptively transferred T cells (293)↑ IFN-γ+ endogenous/adoptively transferred CD8+ T cells (293)"}

    TEST0

    {"project":"TEST0","denotations":[{"id":"31244820-14-21-3850288","span":{"begin":94,"end":97},"obj":"[\"25739764\"]"},{"id":"31244820-21-28-3850289","span":{"begin":121,"end":124},"obj":"[\"25739764\"]"},{"id":"31244820-24-31-3850290","span":{"begin":150,"end":153},"obj":"[\"25739764\"]"},{"id":"31244820-34-41-3850291","span":{"begin":190,"end":193},"obj":"[\"25739764\"]"},{"id":"31244820-34-41-3850292","span":{"begin":277,"end":280},"obj":"[\"25739764\"]"},{"id":"31244820-95-102-3850293","span":{"begin":338,"end":341},"obj":"[\"25739764\"]"}],"text":"ACT \u0026 intratumoral hypoxia aversion ➣ Respiratory hyperoxia (60%O2)\n➣ T cells:\nTDLN-derived (293) ➣ Melanoma: B16-F10 (293)\n➣ Fibrosarcoma: MCA205 (293) ➣ Primary tumor expansion rate ↓ (293)\nHost A2AR (293)\n➣ Metastasis formation ↓ (293) ↑ Adoptively transferred T cells (293)↑ IFN-γ+ endogenous/adoptively transferred CD8+ T cells (293)"}

    2_test

    {"project":"2_test","denotations":[{"id":"31244820-25739764-35366140","span":{"begin":94,"end":97},"obj":"25739764"},{"id":"31244820-25739764-35366141","span":{"begin":121,"end":124},"obj":"25739764"},{"id":"31244820-25739764-35366142","span":{"begin":150,"end":153},"obj":"25739764"},{"id":"31244820-25739764-35366143","span":{"begin":190,"end":193},"obj":"25739764"},{"id":"31244820-25739764-35366144","span":{"begin":277,"end":280},"obj":"25739764"},{"id":"31244820-25739764-35366145","span":{"begin":338,"end":341},"obj":"25739764"}],"text":"ACT \u0026 intratumoral hypoxia aversion ➣ Respiratory hyperoxia (60%O2)\n➣ T cells:\nTDLN-derived (293) ➣ Melanoma: B16-F10 (293)\n➣ Fibrosarcoma: MCA205 (293) ➣ Primary tumor expansion rate ↓ (293)\nHost A2AR (293)\n➣ Metastasis formation ↓ (293) ↑ Adoptively transferred T cells (293)↑ IFN-γ+ endogenous/adoptively transferred CD8+ T cells (293)"}